SITC
SITE Centers Corp.
$3.72
-0.02
(-0.53%)
Mkt Cap
195.21M
Volume
2,624,878
52W Range
2.8-8.91
Sector
Real Estate
Beta
1.02
EPS (TTM)
2.44 USD
P/E Ratio
1.52
Revenue (TTM)
70.88M USD
Rev Growth (5Y)
-23.2%
EPS Growth (5Y)
+35.6%
Company Description
SITE Centers specializes in the ownership and management of open-air retail complexes, curating an engaging shopping atmosphere and a desirable selection of stores for both its retail tenants and their customers. As a self-governing Real Estate Investment Trust (REIT), the company operates as a fully integrated real estate enterprise, managing all aspects of its operations internally. Its shares are publicly available on the New York Stock Exchange under the ticker symbol SITC.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 123.17M | 277.47M | 452.62M | 479.22M | 532.86M | 460.33M | 507.10M | 654.86M | 879.45M | 969.51M | 995.10M | 953.77M |
| Net Income | 177.86M | 531.82M | 265.70M | 168.72M | 124.94M | 35.72M | 100.70M | (109.30M) | (241.69M) | 60.01M | (72.17M) | 117.28M |
| EPS | 3.39 | 9.81 | 4.85 | 2.96 | 2.04 | 0.74 | 2.20 | -2.37 | -5.26 | 1.31 | -1.60 | 2.00 |
| Free Cash Flow | 19.61M | 56.05M | 238.53M | 257.26M | 282.51M | 190.17M | 179.76M | 264.81M | 410.41M | 462.92M | 434.59M | 420.28M |
| FCF / Share | 0.37 | 1.07 | 4.56 | 4.83 | 5.43 | 3.93 | 3.93 | 5.74 | 8.94 | 10.14 | 9.63 | 9.39 |
| Operating CF | 19.61M | 114.84M | 238.53M | 257.26M | 282.51M | 190.17M | 289.12M | 264.81M | 410.41M | 462.92M | 434.59M | 420.28M |
| Total Assets | 418.74M | 933.60M | 4.06B | 4.05B | 3.97B | 4.11B | 4.09B | 4.21B | 7.17B | 8.20B | 9.10B | 9.54B |
| Total Debt | 74.24M | 301.37M | 1.63B | 1.71B | 1.68B | 2.07B | 1.85B | 1.98B | 3.85B | 4.49B | 5.14B | 5.23B |
| Cash & Equiv | 119.03M | 54.59M | 551.97M | 20.25M | 41.81M | 69.74M | 16.08M | 11.09M | 92.61M | 30.43M | 22.42M | 20.94M |
| Book Value | 334.76M | 516.74M | 2.18B | 2.09B | 2.04B | 1.94B | 1.98B | 2.07B | 2.89B | 3.24B | 3.46B | 3.77B |
| Return on Equity | 0.53 | 1.03 | 0.12 | 0.08 | 0.06 | 0.02 | 0.05 | -0.05 | -0.08 | 0.02 | -0.02 | 0.03 |
| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.81M | 12.98M | 19.98M | 27.10M | 33.47M | 42.62M | (51.06M) | 90.76M | 115.67M | 94.05M | 124.67M | 144.76M |
| Net Income | (1.30M) | 938,000 | 134.43M | (6.16M) | 46.50M | 3.08M | (5.82M) | 322.95M | 238.25M | (23.55M) | 196.42M | 48.64M |
| EPS | -0.02 | 0.02 | 2.58 | -0.13 | 0.88 | 0.06 | -0.25 | 6.09 | 4.48 | -0.51 | 3.68 | 0.87 |
| Free Cash Flow | (11.29M) | (7.17M) | (8.47M) | 5.15M | 15.88M | 2.48M | (30.68M) | 36.76M | 66.49M | 39.95M | 19.23M | 35.75M |
| FCF / Share | -0.22 | -0.14 | -0.16 | 0.10 | 0.30 | 0.05 | -0.59 | 0.70 | 1.27 | 0.76 | 0.37 | 0.68 |
| Operating CF | (10.15M) | (4.31M) | (8.47M) | 5.15M | 17.65M | 5.72M | (29.75M) | 36.76M | 66.49M | 39.95M | 47.83M | 65.25M |
| Total Assets | 365.29M | 401.92M | 418.74M | 653.96M | 959.04M | 929.75M | 933.60M | 3.13B | 4.05B | 3.89B | 4.06B | 4.03B |
| Total Debt | 0 | 0 | 0 | 248.70M | 288.44M | 301.64M | 301.37M | 300.84M | 1.51B | 1.57B | 1.60B | 1.74B |
| Cash & Equiv | 238.93M | 193.45M | 119.03M | 128.23M | 153.79M | 58.16M | 54.59M | 1.06B | 1.18B | 551.28M | 551.97M | 26.56M |
| Book Value | 282.26M | 335.95M | 334.76M | 308.29M | 486.68M | 519.62M | 516.74M | 2.65B | 2.33B | 2.12B | 2.18B | 2.05B |
| Return on Equity | -0.00 | 0.00 | 0.40 | -0.02 | 0.10 | 0.01 | -0.01 | 0.12 | 0.10 | -0.01 | 0.09 | 0.02 |
SITC News
GT Biopharma Selected for Oral Presentation at the SITC 2026 Annual Meeting
Pine Tree Acquires Sponsor Interest in a 10-Property, $644M Shopping Center Portfolio
SITE Centers Announces Sale of DTP Interests and Special Common Distribution
Aptevo to Showcase Multispecific Platform at SITC 2026 Annual Meeting
BriaCell and BriaPro to Present Four Posters at SITC 2026 Annual Meeting
Critical Comparison: Deutsche Bank Aktiengesellschaft (NYSE:DB) vs. Site Centers (NYSE:SITC)
Perspective Therapeutics Announces Acceptance of [212Pb]VMT01 Data for Presentation at SITC 2026
Obsidian Therapeutics to Present Updated Amsoki-cel (OBX-115) Phase 1/2 Data in Advanced Melanoma at SITC 2026 Annual Meeting
Agenus to Present BOT+BAL Long-Term Survival Data and Translational Research With agenT-797 in Colorectal Cancer at SITC 2026
Obsidian Therapeutics to Present Updated Amsoki-cel (OBX-115) Phase 1/2 Data in Advanced Melanoma at SITC 2026 Annual Meeting